DealsSelling your emerging life-science company: Earnouts and special holdbacks hitting your closing-date payoutByPE Hub Staff18 September 2017•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsNorth AmericaUSCommentary